Biogen Idec's hemophilia therapeutic area is focused on developing next-generation biopharmaceuticals that enable better treatment options for patients with chronic hematologic disorders. Using proprietary technologies, we aim to develop long-acting biopharmaceuticals that may improve the lives of individuals with hemophilia.
We hire talented individuals who have a high level of commitment to science and who want to be part of an entrepreneurial environment. We look for highly qualified people who want to make a difference in people's lives to join our team.
View Jobs
|
